Side Effect of Eteplirsen?
Posted by: Christine McSherry on May 06, 2013
I think we just identified a side effect of eteplirsen, really great dance moves! Seriously, watching this video on facebook this morning after writing the post about Jett’s prom last week – inspired me and the lit the fire again. The only side effect in this potentially lifesaving drug is running, walking longer, raising arms over head, swimming in the pool, playing basketball and dancing - acting like a normal school age kid.
Sarepta created a drug to make dystrophin in the body. Biopsies from all the participants show dystrophin. Check. Sarepta’s compound, eteplirsen has a negative charge, this reduced the risk of side effects. No side effects. Check. If eteplirsen was creating biologically active dystrophin, its reasonably likely that it would be seen by some functional benefit, dancing? Check. Why do you think I consider this a functional benefit – I think it will be really useful at his junior prom.
Click here to view video
Should Sarepta consider bringing this dance video to the FDA – compared with my pics of Jett at his junior prom last week? Knowing the conversations that I have had with Drs. Woodcock, Katz, Temple and Commission Hamburg, I am confident that they would be impressed and they will want to keep this little guy dancing for as long as he can…
Bookmark the permalink | Tagged dmd, duchenne, Duchenne muscular dystrophy, eteplirsen, muscular dystrophy, sarepta
pdufa fda patient-directed drug development patient perspectives duchenne muscular dystrophy harrison's fund duchenne allinace duchenne research alliance international invitation meeting duchenne muscular dystophy dmd treatment exon skipping sarepta eteplirsen dmd Permissible Risk Patient Perspective Duchenne Alliance PDUFA-V Fast Track Accelerated Approval Priority Review IND NDA Breakthrough therapy exon-skipping Duchenne muscular dystrophy collaboration rigorous review higher resolution. duchenne advocacy treatments pfizer children's hospital boston srpt $srpt jett foundation gower test biotech cambridge becker forbes healthcare rare disease new york times boston daily news prosensa moms morpholinos team community congress race to yes obama washington dc racetoyes washington white house petition fox business fox news stossel willis report government